Vaxart, Inc. (VXRT)

NASDAQ: VXRT · Real-Time Price · USD

0.4000

+0.0203 (5.35%)

Nov 7, 2025, 11:43 AM EST - Market open

Vaxart Employees

Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.

Employees

105

Change (1Y)

-4

Growth (1Y)

-3.67%

Revenue / Employee

$768,800

Profits / Employee

-$539,448

Market Cap

91.38M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	105	-4	-3.67%
Dec 31, 2023	109	-55	-33.54%
Dec 31, 2022	164	54	49.09%
Dec 31, 2021	110	82	292.86%
Dec 31, 2020	28	14	100.00%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

VXRT News

4 hours ago - Vaxart to Host Upcoming Conference Calls - GlobeNewsWire
1 day ago - Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program - PRNewsWire
1 day ago - Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program - PRNewsWire
4 weeks ago - Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025 - GlobeNewsWire
7 weeks ago - Vaxart Appoints W. Mark Watson as Lead Independent Director - GlobeNewsWire
2 months ago - Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate - GlobeNewsWire
2 months ago - Concerned Vaxart Stockholders Condemn Board's Decision to Adjourn Reverse Stock Split Vote at Special Meeting - GlobeNewsWire
2 months ago - Vaxart Announces Adjournment of Special Meeting of Stockholders - GlobeNewsWire